• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Propofol

Propofol

Product ID P6870
Cas No. 2078-54-8
Purity ≥98%
Product Unit SizeCostQuantityStock
5 g $45.40 In stock
25 g $86.80 In stock
100 g $142.50 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Propofol is an agonist at GABA-A receptors and antagonist at voltage-gated Na+ channels and NMDA receptors; it also modulates Ca2+ signaling. Propofol displays anesthetic, sedative/hypnotic, neuroprotective, and nephroprotective activities. Propofol is a short-acting intravenous anesthetic that depresses the central nervous system, decreases cerebral blood flow, and decreases intracranial pressure. In a middle cerebral artery occlusion (MCAO) model of cerebral ischemia/reperfusion, propofol decreases expression of aquaporins 1 and 4 (AQ-1 and AQ-4), matrix metalloproteinases 2 and 9 (MMP2/9), and HIF-1α, decreasing edema and disruption of the blood-brain barrier. Propofol also increases expression of μ-opioid receptors in neuroblastoma cells. Additionally, this compound normalizes osmolality, serum creatine, and levels of AQP-2, ICAM-1, TNF-α, Bcl-2, and Bax in kidneys, improving renal function in animal models of endotoxemia-induced kidney injury.

Product Info

Cas No.

2078-54-8

Purity

≥98%

Formula

C12H18O

Formula Wt.

178.27

IUPAC Name

2,6-di(propan-2-yl)phenol

Synonym

2,6-Bis(isopropyl)phenol, 2,6-Diisopropylphenol

Solubility

100mM in DMSO and ethanol

Appearance

Yellow to red liquid

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

P6870 MSDS PDF

Info Sheet

P6870 Info Sheet PDF

References

Lee JH, Cui HS, Shin SK, et al. Effect of propofol post-treatment on blood-brain barrier integrity and cerebral edema after transient cerebral ischemia in rats. Neurochem Res. 2013 Nov;38(11):2276-86. PMID: 23990224.

Li Z, Pei Q, Cao L, et al. Propofol increases µ-opioid receptor expression in SH-SY5Y human neuroblastoma cells. Mol Med Rep. 2012 Dec;6(6):1333-6. PMID: 22965315.

Cui WY, Tian AY, Bai T. Protective effects of propofol on endotoxemia-induced acute kidney injury in rats. Clin Exp Pharmacol Physiol. 2011 Nov;38(11):747-54. PMID: 21824173.

Kotani Y, Shimazawa M, Yoshimura S, et al. The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci Ther. 2008 Summer;14(2):95-106. PMID: 18482023.

Salmi E, Kaisti KK, Metsähonkala L, et al. Sevoflurane and propofol increase 11C-flumazenil binding to gamma-aminobutyric acidA receptors in humans. Anesth Analg. 2004 Nov;99(5):1420-6. PMID: 15502041.

Yamanoue T, Brum JM, Estafanous FG. Vasodilation and mechanism of action of propofol in porcine coronary artery. Anesthesiology. 1994 Aug;81(2):443-51. PMID: 8053594.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • L9704

    LY-2603618

    Chk1 inhibitor.

    ≥98%
  • P465822

    Pluripotin

    Dual kinase and GTPase inhibitor.

    ≥98%
  • L2800

    LH846

    Casein kinase 1α/δ/ε inhibitor.

    ≥98%
  • G0000

    G250.A2 Peptide

    Peptide, carbonic anhydrase G250 epitope.

    ≥95%
  • N3452

    Nimustine Hydrochloride

    Nitrosourea, DNA cross-linker.

    ≥97%
  • J3205

    Z-JIB-04

    Jumonji histone demethylase inhibitor.

    ≥98%
  • L5873

    Losartan Potassium

    AT1 antagonist.

    ≥98%
  • E5575

    Entacapone

    COMT inhibitor.

    ≥98%
  • T4400

    TL-32711

    Smac mimetic; IAP inhibitor.

    ≥98%
  • M1877

    Methylprednisolone

    Synthetic steroid; glucocorticoid agonist.

    ≥96%
  • T0299

    Tazobactam Sodium

    β-lactamase inhibitor.

    ≥98%
  • N5768

    Norfloxacin

    Fluoroquinolone; topoisomerase IV and bacterial...

    ≥98%
  • H1662

    HER2/neu (654-662) GP2

    Peptide fragment of HER2/neu/erbB2 receptor.

    ≥95%
  • O1176

    n-Octyl Caffeate

    Caffeic acid derivative.

    ≥98%
  • B8074

    3-tert-Butyl-5-Methoxy-1,2-quinone

    BHA derivative.

    ≥98%
  • F4557

    Floxuridine

    5-Fluorouracil derivative, fluorinated pyrimidi...

    ≥98%
  • I4934

    Imipenem Monohydrate

    Carbapenem β-lactam; penicillin binding protei...

    ≥98%
  • C6818

    Crenolanib

    FLT3, PDGFR inhibitor.

    ≥98%
  • C016481

    Camalexin

    Phytoalexin

    ≥98%
  • I0801

    IC261

    Casein kinase 1 inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only